Mylan has entered into a sub-licensing agreement with the Medicines Patent Pool, a UN-backed public health organisation, to expand access to chronic hepatitis C medicines in developing countries.
India-based drugs company Sun Pharma has agreed to acquire Russia-based pharmaceutical business Biosintez.
Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.
Pharmaceutical company GSK has triumphed in a trademark infringement dispute in India.
India-based pharmaceutical company Sun Pharma has agreed to acquire Ocular Technologies for $40 million.
Japanese pharmaceutical company Astellas and German biopharmaceutical company Ganymed have entered into an agreement under which Astellas will acquire Ganymed for €422 million.
Japanese company Sumitomo Dainippon Pharma’s US subsidiary, Sunovion Pharmaceuticals, has completed the acquisition of Cynapsus Therapeutics.
Healthcare company Novartis has won a domain name dispute at the World Intellectual Property Organization Arbitration and Mediation Center.
Indian pharmaceutical company Sun Pharma and the International Centre for Genetic Engineering and Biotechnology have entered into an exclusive collaboration to develop a novel dengue vaccine for India and global markets.
India-based Piramal Enterprises has signed an agreement with Belgian pharmaceutical company Janssen under which Piramal will acquire five anaesthesia and pain management products for $155 million in cash.